UBS Group’s Repligen RGEN Stock Holding History

UBS Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,900	Closed	-$2.14M	–	9903
2023 Q4	$2.14M	Sell	11,900 -600	-5%	-$93.4K	﹤0.01%	3750
2023 Q3	$1.99M	Sell	12,500 -2,500	-17%	-$409K	﹤0.01%	3439
2023 Q2	$2.12M	Buy	15,000 +5,000	+50%	+$802K	﹤0.01%	3465
2023 Q1	$1.68M	Buy	+10,000	New	+$1.78M	﹤0.01%	3607
2022 Q2	–	Sell	-2,000	Closed	-$376K	–	10829
2022 Q1	$376K	Buy	+2,000	New	+$380K	﹤0.01%	4899
2020 Q4	–	Sell	-18,000	Closed	-$2.66M	–	8685
2020 Q3	$2.66M	Buy	+18,000	New	+$2.57M	﹤0.01%	2778
2016 Q3	–	Sell	-40,000	Closed	-$1.09M	–	7888
2016 Q2	$1.09M	Buy	+40,000	New	+$1.02M	﹤0.01%	3312
2015 Q4	–	Sell	-85,000	Closed	-$2.37M	–	8530
2015 Q3	$2.37M	Buy	+85,000	New	+$3.07M	﹤0.01%	2583
2015 Q1	–	Sell	-2,100	Closed	-$42K	–	9269
2014 Q4	$42K	Buy	+2,100	New	+$47K	﹤0.01%	6703

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

UBS Group's RGEN Position: Q2 2026 in Review

UBS Group increased its Repligen (RGEN) stake by 19% in Q2 2026, buying an estimated $15.3M and bringing the position to 795,009 shares worth $108M. The position accounts for 0.01% of the portfolio, ranked #1065.

UBS Group first reported a position in RGEN in Q4 2014 and has held it in 47 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

UBS Group held 795,009 shares of Repligen worth $108M as of Q2 2026.
UBS Group bought 124,680 Repligen shares in Q2 2026, an estimated $15.3M.
Repligen made up 0.01% of UBS Group's portfolio in Q2 2026, its #1065 holding.
UBS Group first reported a position in Repligen in Q4 2014 and has held it in 47 quarters since.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.